309 related articles for article (PubMed ID: 7687532)
1. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
Yu ZY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
[TBL] [Abstract][Full Text] [Related]
4. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
Jiang MD
Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810
[TBL] [Abstract][Full Text] [Related]
5. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
7. [Superinfection of hepatitis viruses].
Chen Z; Liu X; Li LY
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Oct; 15(5):275-7. PubMed ID: 7532107
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis markers in Malaysians with hepatocellular carcinoma.
Lopez JB; Thambyrajah V; Balasegaram M; Satgunasingam N
Br J Biomed Sci; 1994 Jun; 51(2):177-80. PubMed ID: 7519505
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to hepatitis C virus among patients with hepatocellular carcinoma and blood donors in Thailand.
Petchclai B; Srivatanakul P; Puntanee K; Hiranras S; Chiewsilp P; Kunakorn M; Liemsuwan C
J Med Assoc Thai; 1992 Jan; 75 Suppl 1():168-71. PubMed ID: 1383370
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
Khin LW; Teo CJ; Guan R
Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
[TBL] [Abstract][Full Text] [Related]
14. A clinicpathological study of hepatocellular carcinoma in Nagasaki, south-western Japan: the association of hepatitis B and C viruses.
Eto H; Toriyama K; Itakura H
Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):88-92. PubMed ID: 7529945
[TBL] [Abstract][Full Text] [Related]
15. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
16. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
18. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
19. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
20. Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma.
Tong MJ; Lee SY; Hwang SJ; Co RL; Lai PP; Chien D; Kuo G
West J Med; 1994 Feb; 160(2):133-8. PubMed ID: 7512778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]